A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Avience Biomedicals Ltd. Company Cash Flow Statement & Analysis
| (Rs in Cr.) | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
| Profit Before Tax | 6.90 | 2.67 | 0.96 |
| Net CashFlow-Operating Activity | 3.20 | 0.23 | 1.59 |
| Net Cash Used In Investing Activity | -8.16 | -4.12 | -1.94 |
| NetCash Used in Fin. Activity | 8.99 | 3.80 | 0.43 |
| Net Inc/Dec In Cash And Equivlnt | 4.04 | -0.09 | 0.08 |
| Cash And Equivalnt Begin of Year | 0 | 0.09 | 0.01 |
| Cash And Equivalnt End Of Year | 4.04 | 0 | 0.09 |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
More Information on Avience Biomedicals Ltd.
-
Avience Biomedicals Ltd. Company Details
- Company Profile
- Company History
- Management Team
- Capital Structure
- Product Mix
- Banker/Auditor/Registrar
-
Avience Biomedicals Ltd. Key Financial Ratios
- Ratios
-
Avience Biomedicals Ltd. Results
- Annual Results
-
Avience Biomedicals Ltd. Financial Data
- Audited Results
- Cash Flow
- Balance Sheet
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+